The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Tesaro
Stock and Other Ownership Interests - Tesaro
 
Research Funding - Merck (Inst); Novartis (Inst); Pfizer (Inst); Tesaro (Inst)

TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial.
 
Shaveta Vinayak
Consulting or Advisory Role - Tesaro
 
Sara M. Tolaney
Consulting or Advisory Role - AstraZeneca; Genentech; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology
Research Funding - Bristol-Myers Squibb; Eisai; Eisai; Exelixis (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Lee Steven Schwartzberg
Honoraria - Amgen; NanoString Technologies; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Caris Life Sciences; Genomic Health; Helsinn Therapeutics; Pfizer; Spectrum Pharmaceuticals; Tesaro
 
Monica M. Mita
Speakers' Bureau - Genentech
 
Georgia Anne-Lee McCann
No Relationships to Disclose
 
Antoinette R. Tan
Honoraria - Agendia
Consulting or Advisory Role - Abbvie
Research Funding - Abbvie (Inst); Advaxis (Inst); Bayer/Onyx (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Caris Centers of Excellence; Caris Life Sciences
 
Andrea Elisabeth Wahner Hendrickson
No Relationships to Disclose
 
Andres Forero-Torres
Speakers' Bureau - Seagen
Research Funding - Tesaro
Patents, Royalties, Other Intellectual Property - Jones Bartlett; UpToDate
 
Carey K. Anders
Consulting or Advisory Role - Angiochem; Genentech/Roche; Kadmon; Lilly; Merrimack; Nektar; Novartis; Sanofi; to-BBB technologies BV
Research Funding - Angiochem (Inst); Cascadian Therapeutics (Inst); Lilly (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); Puma Biotechnology (Inst); Sanofi (Inst); Tesaro (Inst); to-BBB technologies BV (Inst)
Patents, Royalties, Other Intellectual Property - Jones and Bartlell; Up to Date.com
 
Gerburg M. Wulf
Research Funding - Merck (Inst); Pfizer (Inst)
 
Patrick M Dillon
No Relationships to Disclose
 
Filipa Lynce
Research Funding - Bristol-Myers Squibb; Pfizer
 
Corrine Zarwan
Honoraria - Perceptive Informatics; Revere Pharmaceuticals
Consulting or Advisory Role - Revere Pharmaceuticals
 
John Kalil Erban
Stock and Other Ownership Interests - Express Scripts; Merck
Consulting or Advisory Role - Tesaro
 
Bruce Jeffrey Dezube
Employment - Tesaro
Stock and Other Ownership Interests - Tesaro
 
Yinghui Zhou
No Relationships to Disclose
 
Nathan Buerstatte
Employment - Tesaro
Stock and Other Ownership Interests - Tesaro
 
Sujata Arora
Employment - Tesaro
Stock and Other Ownership Interests - Medtronic; Tesaro
 
Haroun Achour
Employment - Tesaro
Stock and Other Ownership Interests - Tesaro
 
Melinda L. Telli
Consulting or Advisory Role - AstraZeneca; Celldex; Pfizer; PharmaMar; Tesaro; Vertex
Research Funding - Abbvie (Inst); Biothera (Inst); Calithera Biosciences (Inst); Genentech (Inst); Medivation (Inst); Novartis (Inst); OncoSec (Inst); Pfizer (Inst); PharmaMar (Inst); Tesaro (Inst); Vertex (Inst)
Other Relationship - G1 Therapeutics